|Day Low/High||159.30 / 161.00|
|52 Wk Low/High||114.27 / 197.00|
Here's what you need to know now for Thursday, Aug. 23.
Let's check out the charts again so see how far this advance might carry.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGN, DSS, ENDP, ICUI, PIH, SPB, SPPI, WAAS, YRD Downgrades: BMA, BRT, ELSE, FRBK, HAE, HSKA, JD, MATW, TCMD, TSG Initiations: ALT, TRTX Read on to get TheStreet Quant Ratings' detailed report:
There's too much evidence of economic strength, so don't interpret these moves as a sign of a real slowdown.
Net income amounts to EUR 491 million supported by increase in underlying earnings Underlying earnings increase by 2% to EUR 1,064 million, or 10% on constant currencies driven by expense savings, a higher investment margin in the Netherlands, performance...
Aegon has agreed to sell its businesses in Czech Republic and Slovakia for EUR 155 million to NN Group.
The Dow Jones Industrial Average declined by 125 points on Monday.
The first is the ISE Equity Ratio which chimed in at 213%, its first reading over 200% since January 26.
This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.
These names are showing technical characteristics of either bullish or bearish reversal patterns over the past week.
We are looking at today's rotation as an opportunity to pick up a high-quality name at a discount.
Botox maker Allergan's CEO is pushing back against activist investors and may get help from the company's latest earnings report.
Recent moves in industrial stocks demonstrate the importance of buying hated stock/groups when your conviction is high.
The drug giant beat analyst expectations for Q2 and issued positive guidance for the rest of the year.
Micron Technology, Intel and Lam Research are good buys on this heat in semiconductors.
U.S. stock futures are mixed as investors react with caution to a broadly worded trade truce between the European Union and the United States; Facebook tanks as the social media giant points to slower growth; AMD swings to a profit; Qualcomm scraps deal for NXP.
Jim Cramer uses PepsiCo's earnings, which crushed analysts' expectations, to illustrate why investors need to do their own homework to find real winners.
Aegon today announces that it has signed an agreement to expand its successful partnership with Banco Santander in Spain.
It's every investor's dream to find a stock that goes up at least 1,000%; here are a few that did.
Shareholders were given the opportunity to choose between receiving the 2017 final dividend of EUR 0.
We are looking to buy into weakness today, even though the market has gotten significantly tougher over the past few days.
Today, at Aegon's first interactive webinar for analysts and investors, CFO Matt Rider will detail the company's ongoing actions to deliver on its financial transformation, approach to capital management and prioritization in capital deployment.
Don't count on it. The fundamentals paint two very different pictures, Cramer says.
Jim discusses Comcast's offer for Fox, Kohl's, Amazon, 3M, JPMorgan, Goldman Sachs, Citigroup and more!
Markets look calm, but we're seeing some extraordinary breakouts, says Jim Cramer.
You should be thinking positively these days if your stock has had a run or even if it hasn't as a preponderance of good things is liable to happen.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.